1. Clinical Overview
A rational, triple-drug, fixed-dose combination (FDC) antihypertensive therapy that provides synergistic blood pressure control through complementary mechanisms: Angiotensin II Receptor Blockade (ARB), Dual L/N-type Calcium Channel Blockade (CCB), and Thiazide-like Diuretic action. This combination is particularly effective for moderate to severe hypertension, offers renal and cardiac protection, and is associated with a lower incidence of peripheral edema compared to other CCBs.
| Onset | Duration | Bioavailability |
|---|---|---|
| Telmisartan: 1-2 hours; Cilnidipine: 1-2 hours; Chlorthalidone: 2-6 hours. | Telmisartan: >24 hours; Cilnidipine: ~24 hours; Chlorthalidone: 24-72 hours. | Telmisartan: ~42-58%; Cilnidipine: ~90%; Chlorthalidone: ~65%. |
2. Mechanism of Action
This combination exerts a multi-pronged attack on hypertension: 1) Telmisartan selectively blocks the binding of angiotensin II to the AT1 receptor, inhibiting vasoconstriction, aldosterone secretion, and sympathetic outflow. 2) Cilnidipine blocks both L-type (vascular) and N-type (neuronal) voltage-gated calcium channels, causing vasodilation and suppressing norepinephrine release from sympathetic nerve endings. 3) Chlorthalidone inhibits sodium reabsorption in the distal convoluted tubule of the nephron, promoting natriuresis and diuresis, reducing plasma volume and peripheral vascular resistance.
3. Indications & Uses
- Essential Hypertension (Moderate to Severe)
- Hypertension not adequately controlled with dual therapy
4. Dosage & Administration
Adult Dosage: One tablet (Telmisartan 40mg + Cilnidipine 10mg + Chlorthalidone 12.5mg) once daily, preferably in the morning.
Administration: Swallow whole with a glass of water, with or without food (but consistent timing is advised). Taking it in the morning minimizes nocturia. Do not crush or chew.
5. Side Effects
Common side effects may include:
- Dizziness/lightheadedness
- Headache
- Fatigue/asthenia
- Peripheral edema (less common with Cilnidipine)
- Hypotension
- Increased urination (initial phase)
- Nausea
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Antihypertensives (ACEi, Beta-blockers, Alpha-blockers) | Additive hypotensive effect, risk of severe hypotension. | Major |
| Potassium-sparing diuretics (Spironolactone, Amiloride), Potassium supplements, Salt substitutes | Increased risk of hyperkalemia (due to Telmisartan). | Major |
| NSAIDs (e.g., Ibuprofen, Diclofenac) | Reduced antihypertensive effect; increased risk of renal impairment and hyperkalemia. | Major |
| Lithium | Chlorthalidone reduces renal clearance of lithium, leading to toxicity. | Major |
| Digoxin | Chlorthalidone-induced hypokalemia can potentiate digoxin toxicity. | Moderate |
| CYP3A4 Inhibitors (Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | Increase Cilnidipine plasma levels, risk of hypotension and edema. | Moderate |
| CYP3A4 Inducers (Rifampicin, Phenytoin, Carbamazepine) | Decrease Cilnidipine plasma levels, reducing efficacy. | Moderate |
| Corticosteroids | Counteract hypokalemic and antihypertensive effects of Chlorthalidone. | Moderate |
| Allopurinol | Increased risk of hypersensitivity reactions when combined with Chlorthalidone. | Moderate |
| Antidiabetic drugs (Insulin, Sulfonylureas) | Chlorthalidone may worsen glycemic control, requiring dose adjustment. | Moderate |
7. Patient Counselling
- DO take the tablet at the same time every day, preferably in the morning.
- DO continue taking even if you feel well; hypertension is often asymptomatic.
- DO get your blood pressure, kidney function, and electrolytes (especially potassium) checked regularly as advised by your doctor.
- DO inform all your doctors and dentists about all medications you are taking.
- DONT stop taking this medicine suddenly without consulting your doctor.
- DONT take over-the-counter NSAIDs (like Ibuprofen) for pain/fever without consulting your doctor.
- DONT use potassium supplements or salt substitutes containing potassium without medical advice.
- DONT become dehydrated. Maintain adequate fluid intake, especially in hot weather or during illness with vomiting/diarrhea.
8. Toxicology & Storage
Overdose: Profound hypotension, tachycardia or bradycardia, dizziness, syncope, electrolyte disturbances (hypokalemia, hyponatremia), dehydration, acute renal failure due to reduced perfusion, and circulatory shock.
Storage: Store below 30°C, in a cool, dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the pack.